Fluorine‐18 labelling of oligonucleotides: Prosthetic labelling at the 5′‐end using the N‐(4‐[18F]fluorobenzyl)‐2‐bromoacetamide reagent
- 29 August 2003
- journal article
- research article
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 46 (12) , 1093-1103
- https://doi.org/10.1002/jlcr.742
Abstract
No abstract availableKeywords
Funding Information
- European contract (QLG1-CT-2000-00562)
This publication has 11 references indexed in Scilit:
- General Method to Label Antisense Oligonucleotides with Radioactive Halogens for Pharmacological and Imaging StudiesBioconjugate Chemistry, 2000
- Fluorine-18 labeling of oligonucleotides bearing chemically?modified ribose?phosphate backbonesJournal of Labelled Compounds and Radiopharmaceuticals, 2000
- Synthesis and Nicotinic Acetylcholine Receptor in Vivo Binding Properties of 2-Fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: A New Positron Emission Tomography Ligand for Nicotinic ReceptorsJournal of Medicinal Chemistry, 1999
- Synthesis of a fluorine-18 labeled derivative of epibatidine for in vivo nicotinic acetylcholine receptor PET imagingBioorganic & Medicinal Chemistry, 1999
- In vivo imaging of oligonucleotides with positron emission tomographyNature Medicine, 1998
- Comparative Pharmacokinetics, Tissue Distribution, and Tumor Accumulation of Phosphorothioate, Phosphorodithioate, and Methylphosphonate Oligonucleotides in Nude MiceAntisense and Nucleic Acid Drug Development, 1997
- A general method for labeling oligodeoxynucleotides with 18F for in vivo PET imagingJournal of Labelled Compounds and Radiopharmaceuticals, 1997
- Antisense TherapeuticsPublished by Springer Nature ,1996
- Pharmacokinetics of Antisense OligonucleotidesClinical Pharmacokinetics, 1995
- Oligonucleoside Methylphosphonates as Antisense ReagentsNature Biotechnology, 1991